Aviso: Este sitio agrega datos públicos oficiales de la FDA, ClinicalTrials.gov, PubMed y SEC EDGAR solo como referencia general. No constituye asesoramiento médico, diagnóstico, recomendaciones de tratamiento ni asesoramiento de inversión.

FDA 510(k)

TELLTALE Electrosurgical Guidewire System

N.º K: K252592 · 2025-11-13

SolicitanteTelltale, LLC
Fecha de decisión2025-11-13
Código de productoSGO
Comité asesorCV
DecisiónSubstantially Equivalent

Resumen del dispositivo

TELLTALE Electrosurgical Guidewire System is the device name listed in this FDA 510(k) record. The listed applicant is Telltale, LLC. It received FDA 510(k) clearance on 2025-11-13 under 510(k) number K252592. The device is classified under product code SGO. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Preguntas frecuentes

What is the TELLTALE Electrosurgical Guidewire System?

TELLTALE Electrosurgical Guidewire System is a medical device that received FDA 510(k) clearance on 2025-11-13. The listed applicant is Telltale, LLC. The 510(k) number is K252592.

When did TELLTALE Electrosurgical Guidewire System receive FDA 510(k) clearance?

TELLTALE Electrosurgical Guidewire System received FDA 510(k) clearance on 2025-11-13, under 510(k) number K252592.

Who is the listed applicant for TELLTALE Electrosurgical Guidewire System?

The FDA 510(k) record lists Telltale, LLC as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for TELLTALE Electrosurgical Guidewire System?

The FDA product code for TELLTALE Electrosurgical Guidewire System is SGO.

Ensayos clínicos relacionados

Los registros relacionados se emparejan automáticamente mediante nombres, códigos de producto u otros metadatos. Un emparejamiento no establece una relación clínica, científica, corporativa o regulatoria verificada; revise las fuentes oficiales enlazadas.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Fuente oficial

Ver en la base de datos de la FDA →

Datos procedentes de la API abierta de la FDA. Para obtener la información más actualizada y autoritativa, consulte siempre el registro oficial.

↑